Analysts’ Viewpoint
Rise in prevalence of peripheral and coronary artery diseases is expected to propel the global atherectomy systems industry growth during the forecast period. Atherectomy is a minimally invasive procedure used to remove plaque buildup from arteries in the body, thereby improving blood flow and reducing the risk of heart attacks or strokes.
Increase in incidence of cardiovascular diseases and rise in awareness about efficient atherectomy treatment are expected to augment market progress in the near future. Leading companies in the global market are focusing on R&D activities to develop new diagnostic technologies. This is likely to offer lucrative growth opportunities for vendors in the industry. Key players are launching advanced medical devices in order to increase their atherectomy systems market share.
Atherectomy systems are medical devices used to remove plaque buildup from the inner walls of arteries to improve blood flow. These systems use various techniques such as laser, ultrasound, or rotational ablation to remove plaque and improve blood flow to the heart, brain, and other vital organs.
Rapidly rise in incidence of cardiovascular diseases is one of the key drivers of the atherectomy systems market growth. Cardiovascular diseases, also known as heart diseases, are a group of conditions that affect the heart and blood vessels. These conditions are the leading cause of death, globally, and are a major public health concern. Increase in prevalence of cardiovascular diseases is majorly due to factors such as unhealthy lifestyles, sedentary jobs, unhealthy diet, and stress.
According to the World Health Organization (WHO), cardiovascular diseases are responsible for over 17 million deaths annually, accounting for 31.0% of all global deaths. Incidence of cardiovascular diseases is expected to increase in the next few years, owing to the significant rise in global aging population. Furthermore, rise in prevalence of chronic conditions, such as high blood pressure, high cholesterol levels, and obesity, is further contributing to the atherectomy systems market development.
Patients are more likely to opt for pain-free minimally invasive procedures that make a smaller incision into the body. Atherectomy procedure is a minimally invasive medical procedure that involves removing plaque or blockages in blood vessels to improve blood flow. It offers several advantages over traditional open surgeries, including faster recovery time, reduced pain, and lower risk of complications.
Minimally invasive procedures are often associated with better patient outcomes, including improved function and appearance. These procedures are less expensive than traditional open surgeries, making them more accessible to a wider patient population. All these factors are projected to fuel global atherectomy systems market size in the near future.
In terms of product type, the directional atherectomy devices segment held major share of the global market in 2021. Increase in prevalence of cardiovascular diseases is likely to drive the segment. Directional atherectomy devices utilize rotating or oscillating blades, laser, or ultrasound energy to remove plaque from the vessel walls. These devices are commonly used in the treatment of peripheral artery diseases.
Based on end-user, the hospitals segment is likely to lead the global market during the forecast period. Rise in geriatric population suffering from severe chronic disorders, improvement in healthcare infrastructure in various regions, and increase in availability of advanced treatments in hospitals are major factors boosting the segment.
Additionally, advancements in medical technology and emergence of new medical devices have significantly improved patient outcomes. Healthcare services in hospitals are more accessible and convenient for patients. Hence, rise in demand for healthcare services has led to an increase in number of hospitals offering specialized services for patients.
North America is expected to be a highly lucrative market during the forecast period. This region held 30.0% share of the global industry in 2021. The atherectomy systems market share held by North America is likely to increase in the near future, owing to the rise in incidence of cardiovascular diseases in the region. The U.S. is projected to dominate the North America market due to the significant presence of major market players in the country along with increase in research and development activities in the field of atherectomy.
The market in Asia Pacific is projected to grow at the highest CAGR during the forecast period, due to the high incidence rate of cardiovascular diseases in the region.
The global market is fragmented, with the presence of large numbers of key players. According to the atherectomy systems market research report, key players are investing in research & development projects, primarily to develop innovative tests such as rapid tests. These players are gaining lucrative atherectomy systems market opportunities by implementing various strategies including expansion of product portfolio and mergers & acquisitions.
As per the atherectomy industry research report, key players in the global market are Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Becton, Dickinson and Company, Cardinal Health Inc, Koninklijke Philips N.V., Medtronic, RA Medical Systems, and Terumo Corporation.
Key players have been profiled in the atherectomy systems market forecast report based on parameters such as product portfolio, business segments, recent developments, company overview, and business strategies.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 621.8 Mn |
|
Market Forecast Value in 2031 |
More than US$ 1.1 Bn |
|
Growth Rate (CAGR) |
6.0% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global market was valued at US$ 621.8 Mn in 2021
It is projected to reach a value of more than US$ 1.1 Bn by 2031
It is anticipated to grow at a CAGR of 6.0% from 2022 to 2031
Rise in prevalence of cardiovascular diseases and increase in demand for minimally invasive procedures
North America is likely to account for major share during the forecast period
Abbott Laboratories, B. Braun SE, Boston Scientific Corporation, Becton, Dickinson and Company, Cardinal Health Inc, Koninklijke Philips N.V., Medtronic, RA Medical Systems, and Terumo Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atherectomy Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Atherectomy Systems Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Atherectomy Systems Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Directional Atherectomy Devices
6.3.2. Rotational Atherectomy Devices
6.3.3. Orbital Atherectomy Devices
6.3.4. Laser Atherectomy Devices
6.3.5. Image-guided Atherectomy Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Atherectomy Systems Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cardiovascular Diseases
7.3.2. Peripheral Artery Diseases
7.3.3. Neurovascular Diseases
7.4. Market Attractiveness Analysis, by Application
8. Global Atherectomy Systems Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory surgical centers & Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Atherectomy Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Atherectomy Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Directional Atherectomy Devices
10.2.2. Rotational Atherectomy Devices
10.2.3. Orbital Atherectomy Devices
10.2.4. Laser Atherectomy Devices
10.2.5. Image-guided Atherectomy Devices
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cardiovascular Diseases
10.3.2. Peripheral Artery Diseases
10.3.3. Neurovascular Diseases
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Ambulatory surgical centers & Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Atherectomy Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Directional Atherectomy Devices
11.2.2. Rotational Atherectomy Devices
11.2.3. Orbital Atherectomy Devices
11.2.4. Laser Atherectomy Devices
11.2.5. Image-guided Atherectomy Devices
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cardiovascular Diseases
11.3.2. Peripheral Artery Diseases
11.3.3. Neurovascular Diseases
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Ambulatory surgical centers & Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Atherectomy Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Directional Atherectomy Devices
12.2.2. Rotational Atherectomy Devices
12.2.3. Orbital Atherectomy Devices
12.2.4. Laser Atherectomy Devices
12.2.5. Image-guided Atherectomy Devices
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cardiovascular Diseases
12.3.2. Peripheral Artery Diseases
12.3.3. Neurovascular Diseases
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Ambulatory Surgical Centres & Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Atherectomy Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Directional Atherectomy Devices
13.2.2. Rotational Atherectomy Devices
13.2.3. Orbital Atherectomy Devices
13.2.4. Laser Atherectomy Devices
13.2.5. Image-guided Atherectomy Devices
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Cardiovascular Diseases
13.3.2. Peripheral Artery Diseases
13.3.3. Neurovascular Diseases
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Ambulatory Surgical Centres & Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Atherectomy Systems Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Directional Atherectomy Devices
14.2.2. Rotational Atherectomy Devices
14.2.3. Orbital Atherectomy Devices
14.2.4. Laser Atherectomy Devices
14.2.5. Image-guided Atherectomy Devices
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Cardiovascular Diseases
14.3.2. Peripheral Artery Diseases
14.3.3. Neurovascular Diseases
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Ambulatory Surgical Centres & Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Abbott Laboratories.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. B. Braun SE
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Becton, Dickinson and Company
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Cardinal Health Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. Koninklijke Philips N.V.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.7. Medtronic
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Type Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. RA Medical Systems
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Type Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. Terumo Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Type Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
List of Tables
Table 01: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Atherectomy Systems Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Atherectomy Systems Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Atherectomy Systems Market Value Share, by Product Type (2021)
Figure 03: Global Atherectomy Systems Market Value Share, by End-user (2021)
Figure 04: Global Atherectomy Systems Market Value Share, by Application (2021)
Figure 05: Global Atherectomy Systems Market Value Share, by Region (2021)
Figure 06: Global Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 07: Global Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 08: Global Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 09: Global Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 10: Global Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 11: Global Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 12: Global Atherectomy Systems Market Value Share Analysis, by Region, 2021 and 2031
Figure 13: Global Atherectomy Systems Market Attractiveness, by Region, 2022-2031
Figure 14: North America Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 15: North America Atherectomy Systems Market Value Share (%), by Country, 2021 and 2031
Figure 16: North America Atherectomy Systems Market Attractiveness, by Country, 2022–2031
Figure 17: North America Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 18: North America Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 19: North America Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 20: North America Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 21: North America Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 22: North America Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 23: Europe Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 24: Europe Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 25: Europe Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031
Figure 26: Europe Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 27: Europe Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 28: Europe Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 29: Europe Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 30: Europe Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: Europe Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 32: Asia Pacific Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 33: Asia Pacific Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 34: Asia Pacific Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031
Figure 35: Asia Pacific Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 36: Asia Pacific Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 37: Asia Pacific Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 38: Asia Pacific Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 39: Asia Pacific Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Asia Pacific Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 41: Latin America Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 42: Latin America Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 43: Latin America Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031
Figure 44: Latin America Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 45: Latin America Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 46: Latin America Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 47: Latin America Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 48: Latin America Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 49: Latin America Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 50: Middle East & Africa Atherectomy Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 51: Middle East & Africa Atherectomy Systems Market Value Share (%), by Country/Sub-region, 2021 and 2031
Figure 52: Middle East & Africa Atherectomy Systems Market Attractiveness, by Country/Sub-region, 2022–2031
Figure 53: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by Product Type, 2021 and 2031
Figure 54: Middle East & Africa Atherectomy Systems Market Attractiveness, by Product Type, 2022–2031
Figure 55: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by Application, 2021 and 2031
Figure 56: Middle East & Africa Atherectomy Systems Market Attractiveness, by Application, 2022–2031
Figure 57: Middle East & Africa Atherectomy Systems Market Value Share Analysis, by End-user, 2021 and 2031
Figure 58: Middle East & Africa Atherectomy Systems Market Attractiveness, by End-user, 2022–2031
Figure 59: Global Atherectomy Systems Market Share Analysis, by Company, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Atherectomy Systems Market
